Service
IFDREAM is a platform that allows the combined study of drug targets identification and pathways modulation in rapidly generated drug-resistant models.
Author
DTI-Tech COO & drug discovery consultant at DTI-Tech
Bellinzona, Switzerland
DTI-Tech is a Swiss biotechnology company focused on innovative drug target identification and rapid generation of resistant disease models. The company develops integrated technologies designed to help pharmaceutical and biotech companies de-risk drug development by identifying therapeutic targets and predicting resistance mechanisms earlier in the preclinical process.
DTI-Tech COO & drug discovery consultant
DTI-Tech
Service
IFDREAM is a platform that allows the combined study of drug targets identification and pathways modulation in rapidly generated drug-resistant models.
DTI-Tech COO & drug discovery consultant at DTI-Tech
Bellinzona, Switzerland